Atomoxetine pilot study in preschool children with ADHD [attention-deficit hyperactivity disorder].
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2012
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 07 Jul 2012 Actual patient number is 31 according to ClinicalTrials.gov.
- 07 Jul 2012 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
- 12 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.